ClinicalTrials.Veeva

Menu
C

Clinical Endpoints | Scottsdale, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

CY6463
Frexalimab
BOTOX
ACU193
SAR441344
Simufilam
NE3107

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 6 total trials
Locations recently updated

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 76 we...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Simufilam

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo
Drug: BOTOX

Trial sponsors

AbbVie logo
A
B
C
Sanofi logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems